Moleculin Biotech, Inc.
MBRX
$0.9502
$0.07538.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.28M | 9.41M | 10.85M | 16.82M | 23.55M |
| Total Receivables | 20.00K | -- | 9.00K | -- | 99.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 565.00K | 2.20M | 2.42M | 2.13M | 2.08M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 331.00K | -- | 457.00K | -- | 545.00K |
| Total Current Assets | 5.19M | 11.61M | 13.73M | 18.96M | 26.27M |
|
|
|||||
| Total Current Assets | 5.19M | 11.61M | 13.73M | 18.96M | 26.27M |
| Net Property, Plant & Equipment | 583.00K | 640.00K | 696.00K | 740.00K | 796.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 11.15M | 11.15M | 11.15M | 11.15M | 11.15M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 16.93M | 23.39M | 25.58M | 30.85M | 38.22M |
|
|
|||||
| Total Accounts Payable | 2.03M | 2.55M | 2.83M | 2.10M | 2.50M |
| Total Accrued Expenses | 3.21M | 2.93M | 2.80M | 3.20M | 4.22M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 120.00K | 116.00K | 112.00K | 109.00K | 100.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 5.36M | 5.59M | 5.75M | 5.41M | 6.82M |
|
|
|||||
| Total Current Liabilities | 5.36M | 5.59M | 5.75M | 5.41M | 6.82M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 358.00K | 390.00K | 420.00K | 450.00K | 474.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.23M | 9.93M | 1.70M | 3.40M | 4.86M |
| Total Liabilities | 10.95M | 15.92M | 7.87M | 9.26M | 12.14M |
|
|
|||||
| Common Stock & APIC | 159.39M | 158.96M | 158.61M | 158.18M | 157.69M |
| Retained Earnings | -153.37M | -151.49M | -140.89M | -136.57M | -131.60M |
| Treasury Stock & Other | -41.00K | 4.00K | -10.00K | -18.00K | -9.00K |
| Total Common Equity | 5.98M | 7.48M | 17.71M | 21.59M | 26.07M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.98M | 7.48M | 17.71M | 21.59M | 26.07M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 5.98M | 7.48M | 17.71M | 21.59M | 26.07M |
|
|
|||||